P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

June 2003

Features

Spotlight

Editorial Board Spotlight: Richard Afable, MD, MPH

P&T highlights the accomplishments of Dr. Afable, a board member since 2000.
Sonja Sherritze

Pediatric Drug Testing Update, United States

The FDA's mandate for improved pediatric labeling may lead to a much-needed increase in research for children's therapies.
Marvin M. Goldenberg, PhD, RPh, MS

Principles of Antibiotic Formulary Selection for P&T Committees: Overview

Burke A. Cunha, MD

Principles of Antibiotic Formulary Selection for P&T Committees: Overview -- Part 1: Antimicrobial Activity

First things first: antimicrobial agents should have a high degree of activity against the pathogens they are intended to treat.
Burke A. Cunha, MD

Continuing Education Credit

Incorporating Omalizumab into Asthma Treatment Guidelines: Consensus Panel Recommendations

A new drug, omalizumab (Xolair™), appears to be effective in overcoming the difficulties in treating persistent and moderate-to-severe asthma.
Lanny J. Rosenwasser, MD, FAAAAI, David B. Nash, MD, MBA, FACP, and members of the Consensus Panel

Departments

Editorial

Say It Ain’t So!

Editor-in-Chief David Nash, MD, MBA, discusses the dangers of violating drug-safety protocols in the name of “improved patient care."
David B. Nash, MD, MBA

Medication Errors

Limiting the Drug Inventory to Minimize Automated Dispensing Equipment Errors

Matthew Grissinger discusses how to reduce errors when using automated drug-dispensing cabinets.
Matthew Grissinger

Prescription Washington

Inspector General Cautions PBMs on Formulary Decision-Making

Stephen Barlas describes the Inspector General's guidelines for PBMs and P&T committees.
Stephen Barlas

Drug News

New Drugs/Drug News

P&T presents the latest information about approvals, indication changes, industry updates, and news from the FDA

Drug Forecast

Alefacept: A New Therapy for Psoriasis

The authors review alefacept (Amevive®) for the treatment of psoriasis.
Larisa Chagan, BS, PharmD